本页面由Tiger Trade Technology Pte. Ltd.提供服务

Cytek BioSciences

4.65
+0.05001.09%
成交量:2.49万
成交额:11.43万
市值:5.98亿
市盈率:-8.93
高:4.65
开:4.56
低:4.56
收:4.60
52周最高:6.18
52周最低:2.37
股本:1.29亿
流通股本:1.09亿
量比:0.39
换手率:0.02%
股息:- -
股息率:- -
每股收益(TTM):-0.5209
每股收益(LYR):-0.5209
净资产收益率:-18.05%
总资产收益率:-5.25%
市净率:1.75
市盈率(LYR):-8.93

数据加载中...

2022/05/12

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/05/11

重要事件披露

8-K - Current report
2022/03/17

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2022/03/17

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2022/03/14

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/03/02

重要事件披露

8-K - Current report
2022/02/28

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/02/23

重要事件披露

8-K - Current report
2022/02/17

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/02/14

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/02/14

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/02/14

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/01/06

重要事件披露

8-K - Current report
2021/09/02

季度报告

Cytek Biosciences, Inc.
2021/07/29

持股变动声明

4 - Statement of changes in beneficial ownership of securities
2021/07/27

重要事件披露

8-K - Current report
2021/07/27

持股变动声明

4 - Statement of changes in beneficial ownership of securities
2021/07/27

持股变动声明

4 - Statement of changes in beneficial ownership of securities
2021/07/23

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2021/07/20

SEC问询函

CORRESP [Cover] - Correspondence